Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hearing Loss

• Different Dosing Regimens of STOP-AST
• Small Sample，Unicentric，Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss
• Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
• Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
• First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss
• SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease
• Effect of Ultrasound-guided Stellate Ganglion Block Combined With Facial Nerve and Glossopharyngeal Nerve Block on the Treatment of Sudden Deafness
• Short-term Steroid for Acute Tinnitus Therapy
• Effect of Donepezil on Speech Recognition in Cochlear Implant Users
• The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
• A Phase IIa, Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Presence of SENS-401 in the Perilymph
• Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
• Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy
• Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency
• Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss
• FX-322 in Adults With Acquired Sensorineural Hearing Loss
• A Trial of LY3056480 in Patients With SNLH
• Phase I Clinical Study of HY01 in Patients
• Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
• Oral Statins and Protection From Hearing Loss
• Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
• Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
• Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
• Noise-Induced Hearing Loss-Acute Exposure Treatment
• Verification of the Efficacy/Safety of the Dual Drug Delivery for Hearing Loss
• FX-322 in Adults With Severe Sensorineural Hearing Loss
• FX-322 in Adults With Age-Related Sensorineural Hearing Loss
• Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
• Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells
• Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
• Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity
• The Effect of PAP on ISSHL Comorbided With OSA
• Effects of Bisphosphonates on OI-Related Hearing Loss
• OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
• Intratympanic Steroids for Sudden Hearing Loss
• FX-322 in Adults With Stable Sensorineural Hearing Loss
• Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2019_20
• Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
• FX-322 in Sensorineural Hearing Loss
• Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss
• Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children
• Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer
• Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy
• Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery
• Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL
• Treating Hearing Loss to Improve Mood and Cognition in Older Adults
• First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation
• High Dose Oral Steroids in Sudden Sensorineural Hearing Loss
• Triamcinolone Levels in Cochlear Perilymph
• Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
• Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss
• Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss
• Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
• Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
• Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
• Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
• Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
• A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
• AM-111 in the Treatment of Acute Inner Ear Hearing Loss
• Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
• Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
• Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
• Protective Effects of EPI-743 on Noise-Induced Hearing Loss
• Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss
• NAC to Prevent Cisplatin-induced Hearing Loss
• Prevention of Noise-induced Hearing Loss
• Sudden Hearing Loss Multi-center Clinical Trial
• Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
• Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study
• Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
• Prevention of Noise-induced Damage by Use of Antioxidants
• Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
• Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
• Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
• Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation
• A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
• Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
• SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
• Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment
• The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
• Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
• Protective Effect of N-acetylcysteine Against From Ototoxicity
• A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
• Fludrocortisone for Sudden Hearing Loss
• The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans
• Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity
• Micronutrients to Prevent Noise-induced Hearing Loss
• Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
• Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation
• Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal
• Protection From Cisplatin Ototoxicity by Lactated Ringers
• Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
• Antioxidation Medication for Noise-induced Hearing Loss
• Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
• Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
• Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
• Neural Changes in the Aging Auditory System
• Sudden Deafness Treatment Trial
• Autoimmunity in Inner Ear Disease